Wide Institutional Variability in the Treatment of Pediatric Critical Asthma: A Multicenter Retrospective Study.
Journal
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653
Informations de publication
Date de publication:
24 Aug 2023
24 Aug 2023
Historique:
medline:
24
8
2023
pubmed:
24
8
2023
entrez:
24
8
2023
Statut:
aheadofprint
Résumé
Children with status asthmaticus refractory to first-line therapies of systemic corticosteroids and inhaled beta-agonists often receive additional treatments. Because there are no national guidelines on the use of asthma therapies in the PICU, we sought to evaluate institutional variability in the use of adjunctive asthma treatments and associations with length of stay (LOS) and PICU use. Multicenter retrospective cohort study. Administrative data from the Pediatric Health Information Systems (PHIS) database. All inpatients 2-18 years old were admitted to a PHIS hospital between 2013 and 2021 with a diagnostic code for asthma. None. This study included 213,506 inpatient encounters for asthma, of which 29,026 patient encounters included care in a PICU from 39 institutions. Among these PICU encounters, large variability was seen across institutions in both the number of adjunctive asthma therapies used per encounter (min: 0.6, median: 1.7, max: 2.5, p < 0.01) and types of adjunctive asthma therapies (aminophylline, ipratropium, magnesium, epinephrine, and terbutaline) used. The center-level median hospital LOS ranged from 1 (interquartile range [IQR]: 1, 3) to 4 (3, 6) days. Among all the 213,506 inpatient encounters for asthma, the range of asthma admissions that resulted in PICU admission varied between centers from 5.2% to 47.3%. The average number of adjunctive therapies used per institution was not significantly associated with hospital LOS (p = 0.81) nor the percentage of encounters with PICU admission (p = 0.47). Use of adjunctive therapies for status asthmaticus varies widely among large children's hospitals and was not associated with hospital LOS or the percentage of encounters with PICU admission. Wide variance presents an opportunity for standardizing care with evidence-based guidelines to optimize outcomes and decrease adverse treatment effects and hospital costs.
Identifiants
pubmed: 37615529
doi: 10.1097/PCC.0000000000003347
pii: 00130478-990000000-00247
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Déclaration de conflit d'intérêts
Dr. Shein received funding from Ceribell and Hill Ward Henderson. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Références
Heneghan JA, Rogerson C, Goodman DM, et al.: Epidemiology of pediatric critical care admissions in 43 United States children’s hospitals, 2014-2019. Pediatr Crit Care Med 2022; 23:484–492
Dharmage SC, Perret JL, Custovic A: Epidemiology of asthma in children and adults. Front Pediatr 2019; 7:246
Chakraborty RK, Basnet S. Status Asthmaticus. 2022 Oct 10. In: StatPearls [Internet]. Treasure Island, FL, StatPearls Publishing, 2023
Carroll CL, Sala KA: Pediatric status asthmaticus. Crit Care Clin 2013; 29:153–166
Newth CJ, Meert KL, Clark AE, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network: Fatal and near-fatal asthma in children: The critical care perspective. J Pediatr 2012; 161:214–21.e3
Bratton SL, Odetola FO, McCollegan J, et al.: Regional variation in ICU care for pediatric patients with asthma. J Pediatr 2005; 147:355–361
Craig SS, Dalziel SR, Powell CV, et al.: Interventions for escalation of therapy for acute exacerbations of asthma in children: An overview of Cochrane Reviews. Cochrane Database Syst Rev 2020; 8:CD012977
Bush A, Fleming L, Saglani S: Severe asthma in children. Respirology 2017; 22:886–897
Rehder KJ: Adjunct therapies for refractory status asthmaticus in children. Respir Care 2017; 62:849–865
Shein SL, Farhan O, Morris N, et al.: Adjunctive pharmacotherapies in children with asthma exacerbations requiring continuous albuterol therapy: Findings from the Ohio pediatric asthma repository. Hosp Pediatr 2018; 8:89–95
Wennberg JE: Unwarranted variations in healthcare delivery: Implications for academic medical centres. BMJ 2002; 325:961–964
Gupta N, Cattamanchi A, Cabana MD, et al.: Implementing pediatric inpatient asthma pathways. J Asthma 2021; 58:893–902
Kaiser SV, Rodean J, Bekmezian A, et al.; Pediatric Research in Inpatient Settings (PRIS) Network: Rising utilization of inpatient pediatric asthma pathways. J Asthma 2018; 55:196–207
Maue DK, Tori AJ, Beardsley AL, et al.: Implementing a respiratory therapist-driven continuous albuterol weaning protocol in the pediatric ICU. Respir Care 2019; 64:1358–1365
Stulce C, Gouda S, Said SJ, et al.: Terbutaline and aminophylline as second-line therapies for status asthmaticus in the pediatric intensive care unit. Pediatr Pulmonol 2020; 55:1624–1630
Tiwari A, Guglani V, Jat KR: Ketamine versus aminophylline for acute asthma in children: A randomized, controlled trial. Ann Thorac Med 2016; 11:283–288
Travers AH, Jones AP, Camargo CA Jr, et al.: Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database Syst Rev 2012; 12:CD010256
Urquhart A, Clarke P: US racial/ethnic disparities in childhood asthma emergent health care use: National Health Interview Survey, 2013-2015. J Asthma 2020; 57:510–520
Hughes HK, Matsui EC, Tschudy MM, et al.: Pediatric asthma health disparities: Race, hardship, housing, and asthma in a national survey. Acad Pediatr 2017; 17:127–134
Shanley LA, Lin H, Flores G: Factors associated with length of stay for pediatric asthma hospitalizations. J Asthma 2015; 52:471–477
Samuels BN, Novack AH, Martin DP, et al.: Comparison of length of stay for asthma by hospital type. Pediatrics 1998; 101:E13
R: A Language and Environment for Statistical Computing. Version 4.0.3. R Foundation for Statistical Computing, 2022. Available at: https://www.R-project.org. Accessed December 4, 2022
Leyenaar JK, Ralston SL, Shieh MS, et al.: Epidemiology of pediatric hospitalizations at general hospitals and freestanding children’s hospitals in the United States. J Hosp Med 2016; 11:743–749
Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl):S94–138
Boeschoten S, de Hoog M, Kneyber M, et al.: Current practices in children with severe acute asthma across European PICUs: An ESPNIC survey. Eur J Pediatr 2020; 179:455–461
Pajno GB, Castagnoli R, Arasi S, et al.: Pediatric use of omalizumab for allergic asthma. Expert Opin Biol Ther 2020; 20:695–703
Messer AF, Sampayo EM, Mothner B, et al.: Continuous albuterol in pediatric acute care: Study demonstrates safety outside the intensive care unit. Pediatr Qual Saf 2019; 4:e225
Andoh AA, Lo CB, Shi J, et al.: Cost analysis of hospitals performing continuous albuterol in non-intensive care settings. J Asthma 2022; 60:314–322
Sjoding MW, Dickson RP, Iwashyna TJ, et al.: Racial bias in pulse oximetry measurement. N Engl J Med 2020; 383:2477–2478
Andrist E, Nuppnau M, Barbaro RP, et al.: Association of race with pulse oximetry accuracy in hospitalized children. JAMA Netw Open 2022; 5:e224584
Savorgnan F, Hassan A, Borges N, et al.: Pulse oximetry and arterial saturation difference in pediatric COVID-19 patients: Retrospective analysis by race. Pediatr Crit Care Med 2023; 24:458–462
Barreto JA, Moynihan KM: Discrimination by design: Is it time to recalibrate interpretation of pulse oximetry? Pediatr Crit Care 2023; 24:517–521
Grunwell JR, Opolka C, Mason C, et al.: Geospatial analysis of social determinants of health identifies neighborhood hot spots associated with pediatric intensive care use for life-threatening asthma. J Allergy Clin Immunol Pract 2022; 10:981–991.e1
Khan S, Bajwa S, Brahmbhatt D, et al.: Multi-level socioenvironmental contributors to childhood asthma in New York City: A cluster analysis. J Urban Health 2021; 98:700–710
Sellers AR, Roddy MR, Darville KK, et al.: Dexamethasone for pediatric critical asthma: A multicenter descriptive study. J Intensive Care Med 2022; 37:1520–1527
Lew A, Morrison JM, Amankwah E, et al.: Heliox for pediatric critical asthma: A multicenter, retrospective, registry-based descriptive study. J Intensive Care Med 2022; 37:776–783